Russian vaccine
Russia’s Sputnik V arrives, officials claim 92% effective
The interim research data of Sputnik V has not been published or peer-reviewed yet
SII to restart COVID vaccine trials as India tally breaches 50L mark
The trials of the Oxford COVID-19 vaccine candidate were halted world over after one volunteer developed 'unexplained illness'
Russia seals deal to supply and test its coronavirus vaccine in India
Dr Reddy’s, one of India’s top pharmaceutical companies, will carry out Phase III clinical trials of Sputnik-V in India, RDIF said
Russia publishes virus vaccine results, weeks after approval
Developers said the vaccine appeared to be safe and to prompt an antibody response in all 40 people tested in the second phase of the study
Russia looking for partnership with India for producing COVID-19 vaccine Sputnik V: RDIF CEO
The vaccine, named Sputnik V, has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF
Russian doctors wary of rapidly approved COVID-19 vaccine: Survey
The vaccine, named ‘Sputnik V’, is yet to complete its final trials and some fear Moscow may be putting national prestige before safety
Experts doubtful about Russian vaccine's effectiveness due to lack of trial data
Russia has only said that the vaccine was tested on 38 people and they have completely recovered.
WHO urge Russia to follow vaccine guidelines
Russia had announced that it will launch vaccine mass production by September and turn out 'several million' doses per month by next year
Five key takeaways from Monday's data on experimental coronavirus vaccines
Oxford University and AstraZeneca announced their vaccine's success in inducing immune responses in volunteers without causing side effects